Similar articles

• Pharmacologic treatment of portal hypertension.

  Rodríguez-Pérez F, Groszmann RJ. Rodríguez-Pérez F, et al. Gastroenterol Clin North Am. 1992 Mar;21(1):15-40. Gastroenterol Clin North Am. 1992. PMID: 1349005 Review.
• Renal effects of drugs used in the treatment of portal hypertension.

  Henriksen JH, Ring-Larsen H. Henriksen JH, et al. Hepatology. 1993 Sep;18(3):688-95. Hepatology. 1993. PMID: 8103034 Review. No abstract available.
• [Vasodilator agents in portal hypertension].

  Combis JM, Vinel JP. Combis JM, et al. Gastroenterol Clin Biol. 1991;15(12):881-7. Gastroenterol Clin Biol. 1991. PMID: 1686004 Review. French. No abstract available.
• [The use of vasodilator agents in the therapy of chronic cardiac insufficiency].

  Koller H, Prager H. Koller H, et al. Wien Med Wochenschr. 1982 Oct 15;132(19):465-70. Wien Med Wochenschr. 1982. PMID: 6129750 German. No abstract available.
• [Pathophysiological and pharmacotherapeutic aspects of portal hypertension].

  Sieber CC, Stalder GA. Sieber CC, et al. Schweiz Med Wochenschr. 1993 Jan 13;123(1-2):3-13. Schweiz Med Wochenschr. 1993. PMID: 8093646 Review. German.